How effective is Viibryd for Obsessive-compulsive Disorder? (a real world drug study)
Summary:
Overall ratings: 2/5 Long term ratings: 2/5
This is a phase IV clinical study of how effective Viibryd (vilazodone hydrochloride) is for Obsessive-compulsive disorder and for what kind of people. The study is created by eHealthMe from 5 Viibryd users and is updated continuously.
What is Viibryd?
Viibryd has active ingredients of vilazodone hydrochloride. It is often used in depression. eHealthMe is studying from 11,106 Viibryd users. Check the latest studies of Viibryd.
What is Obsessive-compulsive disorder?
Obsessive-compulsive disorder (an anxiety disorder characterized by intrusive thoughts that produce uneasiness, apprehension, fear, or worry;) is found to be associated with 677 drugs and 1,312 conditions by eHealthMe. Check the latest studies of Obsessive-compulsive disorder.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
5 people are studied for taking Viibryd in Obsessive-compulsive disorder
Overall effectiveness (number of people):
Long term (1+ years) effectiveness (number of people):
Viibryd effectiveness for Obsessive-compulsive disorder (number of people):
Overall:
- not at all: 1
- somewhat: 3
- moderate: 1
- high: 0
- very high: 0
Long Term:
- not at all: 0
- somewhat: 1
- moderate: 0
- high: 0
- very high: 0
Gender of people who take Viibryd for Obsessive-compulsive disorder *:
- female: 80 %
- male: 20 %
Age of people who take Viibryd for Obsessive-compulsive disorder *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 20 %
- 20-29: 20 %
- 30-39: 20 %
- 40-49: 40 %
- 50-59: 0.0 %
- 60+: 0.0 %
Who find Viibryd more effective for Obsessive-compulsive Disorder?
* Approximation only. Some reports may have incomplete information.
Do you take Viibryd?
- You can start a phase IV clinical trial to monitor Viibryd safety and effectiveness.How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Related studies
Alternative drugs to, pros and cons of:
- Viibryd (11,106 reports)
Treatments, associated drugs and conditions:
- Obsessive-compulsive disorder (22,287 reports)
How the study uses the data?
The study is based on vilazodone hydrochloride (the active ingredients of Viibryd) and Viibryd (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study neither.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Centrum and Tiotropium Bromide - 19 seconds ago
- Drug interactions of Brexpiprazole and Morphine - 30 seconds ago
- Magnevist and Muscle Atrophy for Men aged 60+ - 38 seconds ago
- Magnevist and Wasting for Men aged 60+ - 38 seconds ago
- Magnevist and Muscle Wasting for Men aged 60+ - 38 seconds ago
- Magnevist and Atrophy Of The Muscles for Men aged 60+ - 38 seconds ago
- Fluorouracil and Vomiting for Women aged 30-39 - 54 seconds ago
- Fluorouracil and Upset Stomach for Women aged 30-39 - 55 seconds ago
- Fluorouracil and Stomach Upset for Women aged 30-39 - 55 seconds ago
- Fluorouracil and Emesis for Women aged 30-39 - 55 seconds ago